BC

Boxer Capital Portfolio holdings

AUM $2.04B
This Quarter Return
-6.33%
1 Year Return
+108.35%
3 Year Return
+260.95%
5 Year Return
+1,103.68%
10 Year Return
AUM
$2.83B
AUM Growth
+$2.83B
Cap. Flow
+$168M
Cap. Flow %
5.92%
Top 10 Hldgs %
45.99%
Holding
98
New
13
Increased
2
Reduced
1
Closed
3
Name Market Value Portfolio Weight Shares or Principal Shares
Change %
Capital Flow
BCAB icon
26
BioAtla
BCAB
$28.5M
$29.1M 1.03%
686,347
RNA icon
27
Avidity Biosciences
RNA
$6.04B
$27.7M 0.98%
1,121,327
CGEM icon
28
Cullinan Oncology
CGEM
$453M
$27.7M 0.98%
1,074,082
DAWN icon
29
Day One Biopharmaceuticals
DAWN
$773M
$27.1M 0.96%
+1,189,943
New +$27.1M
AMRN
30
Amarin Corp
AMRN
$315M
$26.3M 0.93%
6,000,000
PNT
31
DELISTED
POINT Biopharma Global Inc. Common Stock
PNT
$25.7M 0.91%
2,500,000
+1,000,000
+67% +$10.3M
PASG icon
32
Passage Bio
PASG
$22.4M
$25.5M 0.9%
1,928,315
KNTE
33
DELISTED
Kinnate Biopharma Inc. Common Stock
KNTE
$24.8M 0.88%
1,065,939
BDTX icon
34
Black Diamond Therapeutics
BDTX
$163M
$24.6M 0.87%
2,014,858
KDMN
35
DELISTED
Kadmon Holdings, Inc.
KDMN
$24M 0.85%
6,205,882
FOLD icon
36
Amicus Therapeutics
FOLD
$2.41B
$22.4M 0.79%
2,325,000
GHRS icon
37
GH Research
GHRS
$865M
$22M 0.78%
+1,013,399
New +$22M
AGEN
38
Agenus
AGEN
$135M
$22M 0.77%
4,000,000
KURA icon
39
Kura Oncology
KURA
$725M
$21.9M 0.77%
1,050,289
BMRN icon
40
BioMarin Pharmaceuticals
BMRN
$11.3B
$20.9M 0.74%
250,000
GOSS icon
41
Gossamer Bio
GOSS
$582M
$20.8M 0.73%
2,562,358
AKRO icon
42
Akero Therapeutics
AKRO
$3.6B
$20.6M 0.73%
831,495
CNTA
43
Centessa Pharmaceuticals
CNTA
$2.07B
$20.1M 0.71%
+904,227
New +$20.1M
MREO
44
Mereo BioPharma
MREO
$275M
$19.7M 0.7%
6,226,673
EPIX icon
45
ESSA Pharma
EPIX
$11.3M
$19.6M 0.69%
687,000
ODT
46
DELISTED
Odonate Therapeutics, Inc. Common Stock
ODT
$19.6M 0.69%
5,607,086
CDAK
47
DELISTED
Codiak BioSciences, Inc. Common Stock
CDAK
$19.1M 0.67%
1,030,065
BCEL
48
DELISTED
Atreca, Inc. Class A Common Stock
BCEL
$18.8M 0.66%
2,202,333
CERE
49
DELISTED
Cerevel Therapeutics Holdings, Inc. Common Stock
CERE
$18.3M 0.65%
714,500
RAIN
50
DELISTED
Rain Oncology Inc. Common Stock
RAIN
$18.3M 0.64%
+1,175,000
New +$18.3M